Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection

Authors:

Abstract
HCV is a leading cause of liver disease, with an estimated 71 million people infected worldwide. During HCV infection, type I interferon (IFN) signaling displays potent antiviral and immunomodulatory effects.
Funding Information
  • Ministry of Science and Technology, Taiwan (106-2320-B-039-042-, 107-2320-B-039-050-)
  • Ministry of Science and Technology, Taiwan (106-2320-B-182-027-MY3, 109-2320-B-182-031-MY3)
  • Chang Gung Medical Foundation (CMRPD1K0071-3, CMRPD1H0211-3, BMRP466)
  • China Medical University, Taiwan (107-S-38, 108-MF-44)